Project overview: The GRAMM Project is an innovative study aimed at bridging the gap in breast cancer-related health disparities. At a juncture when patients are actively engaged in their breast cancer screening care, all patients presenting for a routine screening mammogram at the Ypsilanti Health Center were offered a risk assessment utilizing a software tool called InheRET. This tool gathers information about personal and family cancer history based on genetic testing criteria from the National Comprehensive Cancer Network, with the goal of identifying those who meet criteria for testing. For those with a positive screen, a direct referral was placed for them to meet with a genetic counselor. Those patients were then followed over time to observe how many followed up with genetic counseling, chose to complete genetic testing, and received their results. A voluntary quantitative survey was offered to all who participated in the risk assessment to gauge the acceptability of the intervention, patient understanding of cancer risk, and possible barriers to testing. Throughout the study, educational events were held with an emphasis on community outreach and trust building around genetics and cancer risk. Patients were also invited to participate in a qualitative component to further evaluate the intervention and explore barriers to care. 

Project data: To date, the GRAMM study has recruited 106 participants, with 54 participants screening positive in the risk assessment. Of those who screened positive, 33 participants made an appointment with genetic counselors, and 18 participants completed testing. 

79 participants completed the quantitative survey, with 78 participants expressing satisfaction with the risk assessment. For 74 participants, this was their first time being offered a breast cancer risk assessment. 

Qualitative Component: The second phase of this study includes a qualitative component to explore facilitators and barriers to genetic counseling, testing, and appointments. This will involve interviewing the participants who screened positive during the risk assessment. The interviews will be separated into two parts, with the first cohort containing those who identified as African American/Black. 10-15 participants will be interviewed from each cohort, with a maximum of 30 participants in total. Each interview will last no more than an hour and will occur via Zoom. Each interview will be recorded, with the transcripts retained, de-identified, and analyzed. Participants will be compensated for completing their interview via a gift card. 

Michigan Medicine improves the health of patients, populations and communities through excellence in education, patient care, community service, research and technology development, and through leadership activities in Michigan, nationally and internationally.  Our mission is guided by our Strategic Principles and has three critical components; patient care, education and research that together enhance our contribution to society.

The candidate for this role will assist with the qualitative component of the study, from interviewing participants to data analysis. The position will take place over 6 months, with a time commitment of 5-10 hours per week. The tasks will include:

• Contacting participants to gauge their interest in participating in the interviews.
• Maintaining accurate records of participants contacted and their responses.
• Scheduling interested participants for their interview during a time convenient for both parties via Zoom.
• Conducting and recording the interviews, ensuring transcriptions are enabled. 
• Uploading recordings and transcriptions to Dropbox after the interview.
• Maintaining patient confidentiality and exhibiting compassion, as these interviews may be sensitive to some participants. 
• Communicating with the study team to promptly address any issues.
• Assisting the study team with data analysis, including coding and thematic analysis.

The candidate should have expertise in qualitative data collection and analysis. It is ideal for this person to have experience using Dedoose.

Positions that are eligible for hybrid or mobile/remote work mode are at the discretion of the hiring department. Work agreements are reviewed annually at a minimum and are subject to change at any time, and for any reason, throughout the course of employment. Learn more about the work modes.

This job posting is for a University of Michigan Temporary position. Temporary employment may be full or part time, but in either case is limited in duration. Please review the full posting description for details.

Michigan Medicine conducts background screening and pre-employment drug testing on job candidates upon acceptance of a contingent job offer and may use a third party administrator to conduct background screenings.  Background screenings are performed in compliance with the Fair Credit Report Act. Pre-employment drug testing applies to all selected candidates, including new or additional faculty and staff appointments, as well as transfers from other U-M campuses.

Job openings are posted for a minimum of seven calendar days.  The review and selection process may begin as early as the eighth day after posting. This opening may be removed from posting boards and filled anytime after the minimum posting period has ended.

The University of Michigan is an equal employment opportunity employer.